Stay updated on Brexpiprazole Safety in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the Brexpiprazole Safety in Alzheimer's Agitation Clinical Trial page.

Latest updates to the Brexpiprazole Safety in Alzheimer's Agitation Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA sitewide notice explains NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry 'Revision: v3.7.0' was added to the study record history. The previous entry 'Revision: v3.6.6' was removed, updating the version list.SummaryDifference0.1%

- Check73 days agoChange DetectedThe revision history now includes Revision: v3.6.6 and removes Revision: v3.6.5, updating the list of recorded revisions for this study record.SummaryDifference0.1%

- Check94 days agoChange DetectedA new revision entry (v3.6.5) is added, replacing the previous v3.6.4 in the study record history, signaling an updated version of the record.SummaryDifference0.1%

Stay in the know with updates to Brexpiprazole Safety in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexpiprazole Safety in Alzheimer's Agitation Clinical Trial page.